Plimoth Trust Co. LLC Sells 630 Shares of Kimberly-Clark Co. (NYSE:KMB)

Plimoth Trust Co. LLC reduced its position in Kimberly-Clark Co. (NYSE:KMB) by 11.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,962 shares of the company’s stock after selling 630 shares during the quarter. Plimoth Trust Co. LLC’s holdings in Kimberly-Clark were worth $706,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. William B. Walkup & Associates Inc. bought a new position in Kimberly-Clark in the 2nd quarter worth $26,000. Crewe Advisors LLC bought a new position in shares of Kimberly-Clark in the first quarter worth about $27,000. New Millennium Group LLC purchased a new stake in shares of Kimberly-Clark during the second quarter worth about $28,000. Strategic Financial Concepts LLC bought a new stake in Kimberly-Clark during the 2nd quarter valued at approximately $32,000. Finally, DiNuzzo Private Wealth Inc. lifted its holdings in Kimberly-Clark by 808.0% in the 3rd quarter. DiNuzzo Private Wealth Inc. now owns 227 shares of the company’s stock worth $32,000 after purchasing an additional 202 shares in the last quarter. 76.29% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Kimberly-Clark news, insider Jeffrey P. Melucci sold 37,699 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $141.42, for a total value of $5,331,392.58. Following the transaction, the insider now owns 19,935 shares in the company, valued at approximately $2,819,207.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Jeffrey P. Melucci sold 37,699 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $141.42, for a total value of $5,331,392.58. Following the transaction, the insider now directly owns 19,935 shares of the company’s stock, valued at approximately $2,819,207.70. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Gonzalo Uribe sold 1,780 shares of the company’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total transaction of $250,695.20. Following the sale, the insider now directly owns 7,377 shares of the company’s stock, valued at approximately $1,038,976.68. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.62% of the company’s stock.

Kimberly-Clark Price Performance

KMB traded down $1.20 during trading on Monday, hitting $144.21. The company’s stock had a trading volume of 2,507,533 shares, compared to its average volume of 2,109,113. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59. The firm has a market capitalization of $48.56 billion, a price-to-earnings ratio of 26.73, a P/E/G ratio of 2.98 and a beta of 0.39. The business’s fifty day simple moving average is $143.15 and its 200 day simple moving average is $138.46. Kimberly-Clark Co. has a twelve month low of $116.63 and a twelve month high of $149.30.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.25. The business had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $5.10 billion. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The company’s revenue was down 2.0% compared to the same quarter last year. During the same period last year, the firm posted $1.65 earnings per share. On average, equities research analysts forecast that Kimberly-Clark Co. will post 7.25 EPS for the current fiscal year.

Kimberly-Clark Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 2nd. Shareholders of record on Friday, September 6th were issued a dividend of $1.22 per share. The ex-dividend date of this dividend was Friday, September 6th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.38%. Kimberly-Clark’s payout ratio is currently 89.71%.

Wall Street Analyst Weigh In

KMB has been the subject of several research analyst reports. BNP Paribas assumed coverage on shares of Kimberly-Clark in a research note on Monday, June 24th. They set a “neutral” rating and a $146.00 target price for the company. Royal Bank of Canada reiterated an “outperform” rating and set a $165.00 price objective on shares of Kimberly-Clark in a research report on Wednesday, July 24th. JPMorgan Chase & Co. increased their price target on Kimberly-Clark from $137.00 to $142.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. StockNews.com lowered shares of Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 30th. Finally, Wells Fargo & Company lowered their target price on Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating for the company in a report on Wednesday, July 24th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Kimberly-Clark presently has a consensus rating of “Hold” and an average price target of $149.14.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.